This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Mild Variant With Low Uroporphyrin I Levels due to a Missense Mutation (A66V) Encoding Residual Uroporphyrinogen III Synthase Activity

Cecilia A. Warner, PhD; Maureen B. Poh-Fitzpatrick, MD; Edith F. Zaider, MS; Shih-Feng Tsai, MD, PhD; Robert J. Desnick, PhD, MD

Arch Dermatol. 1992;128(9):1243-1248.

Abstract
• Background and Design.—
Congenital erythropoietic porphyria, an inborn error of heme biosynthesis, results from the deficient activity of the enzyme uroporphyrinogen III synthase. The clinical manifestations in unrelated patients with this autosomal recessive disorder are remarkedly variable, ranging from mild cutaneous involvement to severe transfusion-dependent hemolytic anemia. Biochemical and molecular studies were undertaken to investigate the nature of the unusually mild phenotype in a 15-year-old boy with only cutaneous manifestations.

Results.—
The proband's levels of total porphyrins, urinary uroporphyrin I, and erythrocyte coproporphyrin I were elevated, but not as dramatically as in other patients with this porphyria. Interestingly, the erythrocyte uroporphyrinogen III synthase activity in the proband was about 21% of the normal mean, indicating the presence of significant residual activity. In cultured lymphoblasts from the proband, his father, and mother, the enzymatic activities were 10%, 70%, and 50% of the normal mean, respectively. Molecular analyses revealed that the proband was heteroallelic for two uroporphyrinogen III synthase missense mutations: the C73R allele inherited from his mother and the A66V allele transmitted by his father. The A66V allele encoded residual enzymatic activity in vitro while the C73R allele did not.

Conclusions.—
The A66V allele accounted for the proband's low levels of porphyrin accumulation and mild clinical manifestations. Such genotype-phenotype correlations should provide understanding of the remarkable clinical variability in other patients with this inherited porphyria.

(Arch Dermatol. 1992;128:1243-1248)

Author Affiliations
From the the Division of Medical and Molecular Genetics (Drs Warner, Tsai, and Desnick), Mount Sinai School of Medicine, New York, NY, and the Department of Dermatology (Dr Poh-Fitzpatrick and Ms Zaider), New York Medical College, Valhalla, NY.

Footnotes
Accepted for publication March 15, 1992.

Reprint requests to Medical and Molecular Genetics, Box 1203, Mount Sinai School of Medicine, Fifth Avenue and 100th Street, New York, NY 10029 (Dr Desnick).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Two Brothers With Mild Congenital Erythropoietic Porphyria Due to a Novel Genotype
Berry et al.
Arch Dermatol 2005;141:1575-1579.
ABSTRACT | FULL TEXT  

Picture of the Month
Shetty et al.
Arch Pediatr Adolesc Med 1999;153:1197-1198.
FULL TEXT